Leowin Healthcare LLP — Sofosbuvir Exporter Profile
Indian Pharmaceutical Exporter · #10 for Sofosbuvir · $140.8K export value · DGFT Verified
Leowin Healthcare LLP is the #10 Indian exporter of Sofosbuvir with $140.8K in export value and 70 verified shipments. Leowin Healthcare LLP holds a 0.3% market share in Sofosbuvir exports across 3 countries. The company exports 5 pharmaceutical products worth $280.2K across 2 therapeutic categories.
Leowin Healthcare LLP — Sofosbuvir Export Profile: Buyers & Destinations
Where Does Leowin Healthcare LLP Export Sofosbuvir?
Leowin Healthcare LLP exports Sofosbuvir to 3 countries. The largest destination is POLAND accounting for 76.4% of Leowin Healthcare LLP's Sofosbuvir shipments, followed by SINGAPORE (21.3%) and CAMBODIA (2.2%). These destinations reflect Leowin Healthcare LLP's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Sofosbuvir from Leowin Healthcare LLP?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | POLAND | $114.2K | 55 |
| TO THE ORDER.. | POLAND | $17.2K | 6 |
| TO THE ORDER OF,,,,, | POLAND | $3.5K | 3 |
| TO THE ORDER....... | POLAND | $3.0K | 1 |
| UNIVERSUM SP ZOOFILIA PRZEMYSLUL LOWOWSKA | POLAND | $2.3K | 4 |
| TO THE ORDER.... | POLAND | $599 | 1 |
Leowin Healthcare LLP supplies Sofosbuvir to 6 buyers globally. The largest buyer is TO THE ORDER (POLAND), followed by TO THE ORDER.. (POLAND) and TO THE ORDER OF,,,,, (POLAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Sofosbuvir Export Value and How Much Does Leowin Healthcare LLP Contribute?
India exported $18.1M worth of Sofosbuvir through 1,341 shipments from 150 suppliers to 113 countries, serving 377 buyers globally. Leowin Healthcare LLP contributes $140.8K to this total, accounting for 0.3% of India's Sofosbuvir exports. Leowin Healthcare LLP ships Sofosbuvir to 3 countries through 6 buyers.
What Is the Average Shipment Value for Leowin Healthcare LLP's Sofosbuvir Exports?
Leowin Healthcare LLP's average Sofosbuvir shipment value is $2.0K per consignment, based on 70 shipments totaling $140.8K. The largest destination is POLAND (76.4% of Leowin Healthcare LLP's Sofosbuvir exports).
How Does Leowin Healthcare LLP Compare to Other Indian Sofosbuvir Exporters?
Leowin Healthcare LLP ranks #10 among 150 Indian Sofosbuvir exporters with a 0.3% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($9.9M), HETERO LABS LIMITED ($5.3M), NATCO PHARMA LIMITED ($800.0K). Leowin Healthcare LLP processed 70 shipments to 3 destination countries.
What Sofosbuvir Formulations Does Leowin Healthcare LLP Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SOFOSBUVIR 400MG & VELPATASVIR 100MG TABLETS OTHER DETAILS AS PER INVOICENOS | $9.0K | 3 |
| (PHARMA ITEMS)(Sofosbuvir 400MG+Velpatasvir100MGTablets)(Sofosbuvir400MG+Velpatasvir100MGTable(OTHER DETAILS AS PER INV) | $9.0K | 4 |
| (PHARMA ITEMS)Sofosbuvir 400MG +Velpatasvir 100MG Tab-Sofosbuvir 400MG + Velpatasvir 100 MGTAB(OTHER DETAILS AS PER INV) | $7.7K | 2 |
| (PHARMA ITEMS)(Sofosbuvir 400MG + Velpatasvir 100MG Tablets)(Sofosbuvir 400MG +Velpatasvir 10(OTHER DETAILS AS PER INV) | $7.3K | 3 |
| (PHARMA ITEMS)(Sofosbuvir 400MG + Velpatasvir 100MG Tablets) - (Sofosbuvir 400MG+ Velpatasvir(OTHER DETAILS AS PER INV) | $6.8K | 1 |
| SOFOSBUVIR 400MG & VELPATASVIR 100MG TABLETS BATCH NO.1903708 MFG DT.JAN-24 EXPDT.DEC-26 OTHER DETAILS AS PER INVOICE | $6.7K | 1 |
| (PHARMA ITEMS)Sofosbuvir 400MG & Velpatasvir 100MG Tab-Sofosbuvir 400MG & Velpatasvir 100 MG (OTHER DETAILS AS PER INV) | $6.6K | 1 |
| (PHARMA ITEMSSofosbuvir 400MG & Velpatasvir 100MG Tablets - Sofosbuvir 400MG & Velpatasvir 100(OTHER DETAILS AS PER INV) | $6.3K | 1 |
| PHARMA ITEMS Sofosbuvir 400MG Velpatasvir 100MGTablets Sofosbuvir 400MG Velpatasvir 100 OTHER DETAILSAS PER INV | $6.2K | 2 |
| PRODUCT NAME:SOFOSBUVIR 400MG & DACLATASVIR 60MG TABLETS IP OTHER DETAILS AS PERINVOICENOS | $5.4K | 2 |
Leowin Healthcare LLP exports 52 distinct Sofosbuvir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SOFOSBUVIR 400MG & VELPATASVIR 100MG TABLETS OTHER DETAILS A with 3 shipments worth $9.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Leowin Healthcare LLP Compare to Nearest Sofosbuvir Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | TROIS BIOTECH PRIVATE LIMITED | $221.0K | 5 | 1 | $44.2K |
| 9 | ASPIDA LIFE SCIENCES PRIVATE LIMITED | $181.5K | 37 | 3 | $4.9K |
| 10 | LEOWIN HEALTHCARE LLP ★ | $140.8K | 70 | 3 | $2.0K |
| 11 | GALAXY SUPER SPECIALITY | $124.8K | 38 | 7 | $3.3K |
| 12 | PROSPERA LIFE SCIENCES PRIVATE LIMITED | $94.3K | 21 | 4 | $4.5K |
Leowin Healthcare LLP ranks #10 among 150 Indian Sofosbuvir exporters. Average shipment value of $2.0K compared to the market average of $120.8K. The closest competitors by value are TROIS BIOTECH PRIVATE LIMITED and ASPIDA LIFE SCIENCES PRIVATE LIMITED.
Which Indian Ports Ship Sofosbuvir Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 357 | 26.6% |
| SAHAR AIR | 269 | 20.1% |
| DELHI AIR CARGO ACC (INDEL4) | 158 | 11.8% |
| Bombay Air | 126 | 9.4% |
| DELHI AIR | 79 | 5.9% |
| AHEMDABAD AIR | 68 | 5.1% |
| AHEMDABAD AIR ACC (INAMD4) | 50 | 3.7% |
| HYDERABAD ACC (INHYD4) | 39 | 2.9% |
What Other Antiviral & HIV Medications Products Does Leowin Healthcare LLP Export?
Leowin Healthcare LLP also exports these antiviral & hiv medications products. Each links to the detailed product page.
About Leowin Healthcare LLP
Leowin Healthcare LLP exports 5 products worth $280.2K. Beyond Sofosbuvir, top products include Velpatasvir, Ledipasvir, Raltegravir, Regorafenib. View the complete Leowin Healthcare LLP profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sofosbuvir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sofosbuvir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Leowin Healthcare LLP matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 70 individual customs records matching Leowin Healthcare LLP exporting Sofosbuvir, covering 52 formulations to 3 countries via 6 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 113+ countries, 377+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sofosbuvir Export Data from Leowin Healthcare LLP
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Leowin Healthcare LLP's Sofosbuvir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Leowin Healthcare LLP
Full Company Profile →
5 products · $280.2K total trade · 2 categories
Sofosbuvir Stats
Company Overview
Top Products by Leowin Healthcare LLP
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Leowin Healthcare LLP.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sofosbuvir. For current shipment-level data, contact TransData Nexus.